Week99er on MSN12h
Sysmex’s PA-100 AST System: Revolutionising UTI diagnosis and treatment with precision
Sysmex’s PA-100 AST System is redefining the standard of care for diagnosing and treating uncomplicated urinary tract ...
Medscape4d
Urine Dipstick Shows Higher Accuracy Than Laboratory Analysis for UTI Detection in Febrile Infants
Urine dipstick demonstrates higher sensitivity and specificity than laboratory urinalysis for diagnosing urinary tract ...
FDA approves first new UTI drug in decades
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
Is Patterson-UTI Energy, Inc. (PTEN) the Best Oil and Gas Dividend Stock According to Billionaires?
We recently published a list of the 12 Best Oil and Gas Dividend Stocks According to Billionaires. In this article, we are ...
Everyday Health on MSN5d
New UTI Antibiotic Is the First Approved by the FDA in Nearly 30 Years
Key TakeawaysBlujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial ...
Financial News18h
Sysmex’s PA-100 AST System Transforms UTI Diagnosis and Antibiotic Selection with Groundbreaking Speed
A leap forward in UTI diagnosis, Sysmex’s PA-100 AST System slashes diagnostic time to just 15 minutes and selects optimal ...
Verywell Health on MSN17h
A New FDA-Approved Antibiotic May Help Women With Recurring UTIs
If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
New Atlas2d
First new stroke and UTI drugs in 30 years get FDA approval
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
Institutional investors in Universal Technical Institute, Inc. (NYSE:UTI) lost 6.0% last week but have reaped the benefits of longer-term growth
If you want to know who really controls Universal Technical Institute, Inc. (NYSE:UTI), then you'll have to look at the makeup of its share registry. The group holding the most number of shares in the ...
Patterson-UTI Energy, Inc. (NASDAQ:PTEN) Given Average Rating of “Moderate Buy” by Analysts
Shares of Patterson-UTI Energy, Inc. (NASDAQ:PTEN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen research firms that are presently covering the firm, ...
Here’s what to know about Blujepa, the new FDA-approved UTI treatment heading to market this year
GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...